Compass Therapeutics (CMPX) Change in Acquisitions & Divestments (2022 - 2026)

Compass Therapeutics has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $83.3 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 128.68% year-over-year to $83.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $148.2 million (up 10.87% YoY) and the FY2025 annual result came in at $101.3 million, down 24.97% from the prior year.
• Change in Acquisitions & Divestments rose to $83.3 million in Q1 2026 per CMPX's latest filing, from $24.1 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $83.3 million in Q1 2026 and troughed at $12.8 million in Q3 2022.
• A 5-year average of $36.7 million and a median of $36.2 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments surged 169.86% in 2023, then tumbled 59.52% in 2025.
• Over 5 years, Change in Acquisitions & Divestments stood at $36.2 million in 2022, then soared by 42.01% to $51.4 million in 2023, then tumbled by 50.91% to $25.2 million in 2024, then retreated by 4.49% to $24.1 million in 2025, then jumped by 245.79% to $83.3 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $83.3 million, $24.1 million, and $13.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.